BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9591024)

  • 21. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
    Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
    Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
    Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
    Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.
    Rosen PP; Lesser ML; Kinne DW; Beattie EJ
    Ann Surg; 1983 Mar; 197(3):276-83. PubMed ID: 6830335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of some clinical and pathological parameters on upper level axillary lymph node involvement in breast cancer.
    Toma S; Leonessa F; Romanini A; Badellino F; Bonassi S; Nicolo G; Rosso R
    Anticancer Res; 1991; 11(4):1439-43. PubMed ID: 1746901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interneural tissue clearance in axillary dissection for breast cancer: What is the importance?
    Patel PK; Sinha AK; Saini S
    Indian J Cancer; 2017; 54(3):539-542. PubMed ID: 29798954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer.
    Zurrida S; Morabito A; Galimberti V; Luini A; Greco M; Bartoli C; Raselli R; Rossi N; Vessecchia G; Cascinelli N; Veronesi U
    Int J Oncol; 1999 Sep; 15(3):475-80. PubMed ID: 10427127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multivariate analysis of clinico-pathologic predictors of axillary lymph node metastasis in invasive breast carcinoma].
    Fehr MK; Köchli OR; Helfenstein U; Schär G; Bussmann C; Fink D; Haller U
    Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):182-8. PubMed ID: 7789705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
    Yu J; Li G; Li J; Wang Y
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new perspective on axillary dissection in situations of metastatic sentinel node].
    Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
    Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
    Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
    Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extent of metastatic axillary involvement in 1446 cases of breast cancer.
    Veronesi U; Luini A; Galimberti V; Marchini S; Sacchini V; Rilke F
    Eur J Surg Oncol; 1990 Apr; 16(2):127-33. PubMed ID: 2323409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary lymph node involvement in stage III breast cancer: treatment implications.
    Voss M; Schneider JW; Apffelstaedt J
    J Surg Oncol; 1999 Jul; 71(3):162-6. PubMed ID: 10404132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.